alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 32.2**

 

**Certification Pursuant to Section 1350of Chapter 63**

**of Title 18 of the United StatesCode**

 

I, Steven T. Campbell,the chief financial officer of United States Cellular Corporation, certify that(i) the quarterly report on Form 10-Q for the first quarter of 2010fully complies with the requirements of Section 13(a) or 15(d) ofthe Securities Exchange Act of 1934 and (ii) the information contained inthe Form 10-Q fairly presents, in all material respects, the financialcondition and results of operations of United States Cellular Corporation.

 

 
|   | /s/ Steven T. Campbell |
|--------|------------------------|
|   | Steven T. Campbell     |
|   | May 10, 2010      |

 

A signed original ofthis written statement required by Section 906 of the Sarbanes-Oxley Actof 2002 has been provided to United States Cellular Corporation and will beretained by U.S. Cellular and furnished to the Securities and ExchangeCommission or its staff upon request.

 

----
<TABLE> <S> <C>

<ARTICLE>                     5
<RESTATED>
       
<S>                                          <C>
<PERIOD-TYPE>                                9-MOS
<FISCAL-YEAR-END>                            MAY-31-1996
<PERIOD-END>                                 FEB-28-1997
<CASH>                                          73,359
<SECURITIES>                                         0
<RECEIVABLES>                                1,849,858
<ALLOWANCES>                                   140,191
<INVENTORY>                                  1,347,004
<CURRENT-ASSETS>                             3,323,442
<PP&E>                                       3,721,501
<DEPRECIATION>                               2,422,660
<TOTAL-ASSETS>                               4,738,307
<CURRENT-LIABILITIES>                        3,199,661
<BONDS>                                      1,078,519
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                    629,172
<COMMON>                                        19,884
<OTHER-SE>                                    (188,929)
<TOTAL-LIABILITY-AND-EQUITY>                 4,738,307
<SALES>                                      9,907,332
<TOTAL-REVENUES>                             9,907,332
<CGS>                                        5,980,556
<TOTAL-COSTS>                                5,980,556
<OTHER-EXPENSES>                             3,439,976
<LOSS-PROVISION>                                49,520
<INTEREST-EXPENSE>                             210,054
<INCOME-PRETAX>                                229,018
<INCOME-TAX>                                     9,328
<INCOME-CONTINUING>                            219,690
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   219,690
<EPS-PRIMARY>                                     0.04
<EPS-DILUTED>                                     0.04
        

</TABLE>
II 

109TH CONGRESS 

1ST SESSION S. 764 

To amend title XVIII of the Social Security Act to improve the coordination 

of prescription drug coverage provided under State pharmaceutical assistance programs with the prescription drug benefit provided under the 

medicare program, and for other purposes. 

IN THE SENATE OF THE UNITED STATES 

APRIL 12, 2005 

Mr. CORZINE (for himself and Mr. LAUTENBERG) introduced the following 

bill; which was read twice and referred to the Committee on Finance 

A BILL

To amend title XVIII of the Social Security Act to improve 

the coordination of prescription drug coverage provided 

under State pharmaceutical assistance programs with the 

prescription drug benefit provided under the medicare 

program, and for other purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Preserving Access to 

5 Affordable Drugs Act of 2005’’. 
2

•S 764 IS

1 SEC. 2. STATE AS AUTHORIZED REPRESENTATIVE. 

2 (a) IN GENERAL.—Section 1860D–1(b)(1) of the So3 cial Security Act (42 U.S.C. 1395w–101(b)(1)) is amend4 ed by adding at the end the following new subparagraph: 

5 ‘‘(D) STATE AS AUTHORIZED REPRESENT6 ATIVE.—A State Pharmaceutical Assistance 

7 Program (as defined in section 1860D–23(b)) 

8 may, at the option of the State operating the 

9 Program, act as the authorized representative 

10 for any part D eligible individual residing in the 

11 State who is enrolled in the Program or de12 scribed in section 1935(c)(6)(A)(ii) in order to 

13 select one or more preferred prescription drug 

14 plans to enroll such an individual, so long as 

15 the individual is afforded the authority to de16 cline such enrollment. A Program that acts as 

17 an authorized representative for an individual 

18 pursuant to the preceding sentence shall not be 

19 considered to have violated section 1860D–

20 23(b)(2) solely because of the enrollment of 

21 such individual in a preferred prescription drug 

22 plan.’’. 

23 (b) CONFORMING AMENDMENT TO ANTI-DISCRIMI24 NATION PROVISION.—Section 1860D–23(b)(2) of the So25 cial Security Act (42 U.S.C. 1395w–133(b)(2)) is amend-
3

•S 764 IS

1 ed by inserting ‘‘subject to 1860D–1(b)(1)(D),’’ after 

2 ‘‘which,’’. 

3 SEC. 3. FACILITATION OF COORDINATION. 

4 Section 1860D–24(c)(1) of the Social Security Act 

5 (42 U.S.C. 1395w–134(c)(1)) is amended by striking ‘‘all 

6 methods of operation’’ and inserting ‘‘its own methods of 

7 operation, except that a PDP sponsor or MA organization 

8 may not require a State Pharmaceutical Assistance Pro9 gram or an RX plan described in subsection (b) to apply 

10 such tools when coordinating benefits’’. 

11 SEC. 4. ALLOWING MEDICAID WRAP. 

12 Section 1935 of the Social Security Act (42 U.S.C. 

13 1396u–5) is amended by striking subsection (d). 

14 SEC. 5. EFFECTIVE DATE. 

15 The amendments made by this Act shall take effect 

16 as if included in the enactment of the Medicare Prescrip17 tion Drug, Improvement, and Modernization Act of 2003 

18 (Public Law 108–173; 117 Stat. 2066).

Æ
[Federal Register Volume 74, Number 95 (Tuesday, May 19, 2009)]
[Notices]
[Pages 23422-23423]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-11599]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee to the Director, Centers for Disease Control 
and Prevention

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC)

[[Page 23423]]

announces the following aforementioned committee meeting:
    Time and Date: 9:30 a.m.-11 a.m., June 4, 2009.
    Place: The teleconference call will originate at the Centers for 
Disease Control and Prevention in Atlanta, Georgia. Please see 
Supplementary Information for details on accessing the teleconference.
    Status: Open to the public, teleconference access limited only by 
availability of telephone ports.
    Purpose: The committee will provide advice to the Director, CDC on 
broad strategies and policy issues facing CDC.
    Matters To Be Discussed: The committee will discuss and vote on 
recommendations regarding CDC Budget Challenges for Fiscal Year 2009 
and beyond; discuss and vote on the updated recommendations from the 
National Biosurveillance Advisory Subcommittee; discuss and vote on the 
mission of the Health Disparities Subcommittee; discuss and vote on the 
Ethic Subcommittee's documents entitled, ``Recommendation on Ethical 
Aspects of Compulsory Use of Travel Restriction Tools''; and 
``Requesting Department of Homeland Security Assistance for Control of 
Communicable Diseases: Standard Operating Procedures;'' and discussion 
of the committee's charge, ``Ethics Subcommittee Input on the Role of 
Social Determinants in Health Reform.''
    Agenda items are subject to change as priorities dictate.

SUPPLEMENTARY INFORMATION: To participate in the teleconference, please 
dial 1-888-820-8958 and enter pass code 6034485.

FOR FURTHER INFORMATION CONTACT: Brad Perkins, M.D., M.B.A., Designated 
Federal Official, Advisory Committee to the Director, CDC, 1600 Clifton 
Road, NE., M/S D-14, Atlanta, Georgia 30333. Telephone 404-639-7000.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: May 13, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E9-11599 Filed 5-18-09; 8:45 am]
BILLING CODE 4163-18-P
EXHIBIT 35.1

                    SERVICER COMPLIANCE STATEMENT (ITEM 1123)

                        RESIDENTIAL FUNDING COMPANY, LLC

             HOME EQUITY LOAN TRUST 2007-HSA2 (THE "ISSUING ENTITY")

The undersigned,  a duly authorized officer of Residential Funding Company, LLC,
as servicer (the  "Servicer")  pursuant to the Pooling and Servicing  Agreement,
dated as of April 1, 2007 (as amended from time to time, the "Agreement"), among
Residential  Funding  Mortgage  Securities  II,  Inc.,  as company,  Residential
Funding Company, LLC, as master servicer, and LaSalle Bank National Association,
as trustee, does hereby certify that:

1. A review of the  Servicer's  activities  during  the  period  covered  by the
Issuing Entity's report on Form 10-K and of the Servicer's performance under the
Agreement has been made under my supervision.

2. To the best of my knowledge, based on such review, the Servicer has fulfilled
all of its obligations under the Agreement in all material  respects  throughout
such period.

IN WITNESS WHEREOF, the undersigned has duly executed this Certificate this 24th
day of March 2008.

By:   /s/ Anthony N. Renzi
      Name:   Anthony N. Renzi
      Title:  Managing Director
EXHIBIT 32.1





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of BSD Medical Corporation (the “Company”) on Form 10-Q for the quarterly period ended February 28, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Harold R. Wolcott, President (Principal Executive Officer) of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:




(1)           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and




(2)           The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.




/s/ Harold R. Wolcott

Harold R. Wolcott

President (Principal Executive Officer)

April 14, 2011
#### Lend-Mor Mortgage Bankers Corp., Respondent, v Edward Nicholas et al., Defendants, and Ameriquest Mortgage Company, Appellant.

Submitted July 17, 2010;

decided September 16, 2010

Motion for leave to appeal dismissed upon the ground that the order sought to be appealed from does not finally determine the action within the meaning of the Constitution.
**EXHIBIT 23.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

Sterling Financial Corporation

Spokane, Washington 

We herebyconsent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-136001, 333-130512, 333-156568, 333-160701, and 333-169579) and Form S-8 (No. 333-144956, 333-141006, 333-136000, 333-139490, 333-111802, 333-105723,333-61452, 333-44078, 333-69481, and 333-171070) of Sterling Financial Corporation, of our reports dated March 8, 2011, relating to the consolidated financial statements, and the effectiveness of Sterling Financial Corporation’sinternal control over financial reporting, which appear in this Form 10-K. 

BDO USA, LLP 

Spokane, Washington 

March 8, 2011
#### UNITED STATES of America, Plaintiff—Appellee, v. Ronald T. MASKO, Defendant—Appellant.

No. 08-6721.

United States Court of Appeals, Fourth Circuit.

Submitted: Jan. 30, 2009.

Decided: May 7, 2009.

*187Ronald T. Masko, Appellant Pro Se. Robert Hugh McWilliams, Jr., Assistant United States Attorney, Wheeling, West Virginia, for Appellee.

Before NIEMEYER, KING, and GREGORY, Circuit Judges.

Dismissed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

Ronald T. Masko seeks to appeal the district court’s order denying his motion to reduce sentence as premature and without prejudice and denying his motion to appoint counsel. The court has since resumed proceedings and appointed counsel. This court may exercise jurisdiction only over final orders, 28 U.S.C. § 1291 (2006), and certain interlocutory and collateral orders, 28 U.S.C. § 1292 (2006); Fed. R.Civ.P. 54(b); *Cohen v. Beneficial Indus. Loan Corp.,*337 U.S. 541, 69 S.Ct. 1221, 93 L.Ed. 1528 (1949). The order Masko seeks to appeal is neither a final order nor an appealable interlocutory or collateral order. Accordingly, we dismiss the portion of the appeal denying Masko’s motion to appoint counsel as moot and dismiss the remainder of the appeal for lack of jurisdiction. We deny Masko’s motion for oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*DISMISSED.*
##### 



Exhibit 32 CERTIFICATION
Pursuant to 18 U.S.C. 1350 as adopted by Section 906 of the Sarbanes-Oxley Act of 2002 Each of the undersigned, Alan J. Lacy, Chairman of the Board of Directors, President and Chief
Executive Officer of Sears, Roebuck and Co. (the Company), and Glenn R. Richter, Executive Vice
President and Chief Financial Officer of the Company, has executed this certification in connection
with the filing with the Securities and Exchange Commission of an amendment to the Companys
Quarterly Report on Form 10-Q for the fiscal quarter ended July 3, 2004 (as amended, the Report). Each of the undersigned hereby certifies that:  1.
    The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and2.
    The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company. February 11, 2005 /s/ Alan J. Lacy
Alan J. Lacy
Chairman of the Board of Directors,
President and Chief Executive Officer /s/ Glenn R. Richter
Glenn R. Richter
Executive Vice President
and Chief Financial Officer
<PAGE>
                                                                  EXHIBIT 10.Q.1

                             AMENDMENT NO. 2 TO THE
                               EL PASO CORPORATION
                         DIRECTOR CHARITABLE AWARD PLAN

      Pursuant to authorization by the El Paso Corporation Board of Directors
(the "Board") and Section 6 of the El Paso Corporation Director Charitable Award
Plan, Amended and Restated effective as of August 1, 1998, as amended (the
"Plan"), the Plan is hereby amended as follows, effective December 4, 2003:

      WHEREAS, the Board, based upon a recommendation from its Compensation
Committee, has determined it is in the best interests of the Company to
terminate the Plan.

      NOW THEREFORE, the Plan is hereby terminated, effective December 4, 2003.
The termination of the Plan does not affect the designation of Charitable Awards
under the Plan by a Participant who has met the two-year service requirement on
the Board and has been notified of his or her eligibility to participate in the
Plan prior to the effective date of this amendment.

      IN WITNESS WHEREOF, the Company has caused this amendment to be duly
executed on this 4th day of December, 2003.

                                                EL PASO CORPORATION

                                                By: /s/ SUSAN B. ORTENSTONE
                                                    ----------------------------
                                                    Susan B. Ortenstone
                                                    Senior Vice President,
                                                    Human Resources

Attest:

  /s/ DAVID L. SIDDALL
------------------------
  Corporate Secretary
EXHIBIT 15




                     (PricewaterhouseCoopers LLP Letterhead)
                                (Minneapolis, MN)


March 29, 2001



Securities and Exchange Commission
450 Fifth Street N.W.
Washington D.C.  20549

Commissioners:

We are aware that our report dated March 23, 2001 on our reviews of the interim
consolidated financial information of Lund International Holdings, Inc. (the
"Company") for the three and six-month periods ended July 2, 2000 and June 30,
1999, and included in the Company's Quarterly Report on Form 10-Q for the
quarter ended July 2, 2000, is incorporated by reference in the Company's
Registration Statements on Form S-8 (Registration Nos. 333-46263, 33-64083 and
33-37160).

Yours very truly,



/s/ PRICEWATERHOUSECOOPERS LLP
PRICEWATERHOUSECOOPERS LLP


                                       23
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. 621 Introduced in Senate (IS)]

109th CONGRESS
  1st Session
                                 S. 621

 To amend the Internal Revenue Code of 1986 to permanently extend the 
   15-year recovery period for the depreciation of certain leasehold 
                             improvements.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             March 15, 2005

  Mr. Conrad (for himself and Mr. Kyl) introduced the following bill; 
     which was read twice and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
 To amend the Internal Revenue Code of 1986 to permanently extend the 
   15-year recovery period for the depreciation of certain leasehold 
                             improvements.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PERMANENT EXTENSION OF 15-YEAR RECOVERY PERIOD FOR 
              DEPRECIATION OF CERTAIN LEASEHOLD IMPROVEMENTS.

    Section 168(e)(3)(E)(iv) of the Internal Revenue Code of 1986 
(defining 15-year property) is amended by striking ``before January 1, 
2006''.
                                 <all>
```
**EXHIBIT 23.1****CONSENT OF INDEPENDENT AUDITORS**     **To the Board of Directors Of Spatializer Audio Laboratories, Inc.:**We consent to the incorporation by reference in the registration statements on Form S-8 (Nos.333-27453 and 333-41170) of Spatializer Audio Laboratories, Inc. ofour report dated February 24,2006, related to the consolidated balance sheets of Spatializer Audio Laboratories, Inc. andsubsidiaries as of December 31, 2005 and December 31, 2004, and the related consolidated statementsof income, stockholders’ equity and comprehensive income and cash flows for each of the years inthe three-year period ended December 31, 2005, which report appears in the annual report on Form10-K of Spatializer Audio Laboratories, Inc. for the year ended December 31, 2005./s/ FARBERHASS HURLEY & MCEWEN LLPCamarillo, CaliforniaFebruary 24, 2006
* Pursuant to 5 TH C IR . R. 47.5, the court has determined

that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. United States Court of Appeals Fifth Circuit 

## FILED November 9, 2005 Charles R. Fulbruge III Clerk IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 05-50622 Summary Calendar

UNITED STATES OF AMERICA, Plaintiff-Appellee,

versus DAVID ARIAS-SETINA, also known as David Arias-Setin, Defendant-Appellant.

-------------------- Appeal from the United States District Court for the Western District of Texas USDC No. 2:04-CR-719-ALL

-------------------- Before REAVLEY, GARZA, and BENAVIDES, Circuit Judges.
PER CURIAM: *Appealing the Judgment in a Criminal Case, David AriasSetina raises arguments that are foreclosed by Almendarez-Torres v. United States , 523 U.S. 224, 235 (1998), which held that a prior conviction is a sentencing factor under 8 U.S.C. § 1326(b)(2) and not a separate criminal offense. The Government’s motion for summary affirmance is GRANTED, and the judgment of the district court is AFFIRMED.
#### ASHLEY et al. v. ATLAS MFG. CO. et al.

Civil Action No. 21298.

District -Court of the United States for the District of Columbia.

July 31, 1946.

Order Affirmed Feb. 3, 1948.

See 166 F.2d 209.

Orín de Motte Walker, of Washington, D. C., for plaintiff.

Samuel B. Brown, of Washington, D. C., for defendant.

McGUIRE, Justice.

This matter came on to be heard at pretrial. There was an informal colloquy as the record indicates, between court and counsel, in which the suggestion of settlement was made and agreed upon between the parties. The Court then directed the official court reporter to make an official record of the terms of settlement, which was done, and which is brief and to the point. It will be noted that counsel for defendants commented upon the fact that the terms of settlement, as dictated by the Court, were correct, and further it will be noted (R.2) that counsel for defendants categorically stated: “I will prepare the release and give him the five thousand.” This has not been done.

While as a matter of law it is true, strictly speaking, an attorney has no right, without special authority, to make a compromise for his client, in this case no question was ever raised as to counsel’s authority until subsequent to the pre-trial proceeding when counsel for defendants advised counsel for the plaintiff that the releases, embodying the terms of the settlement thus recorded, were not to be executed. The record speaks for itself and this Court is of the opinion that both counsel and client should be bound by the solemn statement thus made in open Court, dictated by the Court to the official court reporter so that there would be no misunderstanding, as to the terms of settlement and not only affirmed by counsel for the defendant but buttressed by his further statement: “I will prepare the release and give him the five thousand.” This was a categorical, unambiguous, unequivocal statement which could lead to no other conclusion both in the minds of opposing counsel and the Court, but that counsel had full authority in the premises to negotiate and enter into this settlement. If, as a matter of fact, counsel had no authority, then the resulting difficulty is one that is a matter of adjustment between him and his client. In the meantime, plaintiff has lost his place on the trial calendar, and is presumably prejudiced in other respects.

I find it difficult and am loathe to believe under the circumstances here set forth that counsel should make such a categorical statement without authority and I can only conclude that it is the defendants who now are seeking to avoid consummation of a settlement into which they solemnly entered.